Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burrows

Showing results (361-370 of 449) with videos related to

Pageof 45
Sort By:
Stroke|February 12, 2026
Intergenerational Conditioning via Intermittent Parental Hypoxia Confers Stroke Resilience in OffspringAhmet B Caglayan, Mustafa C Beker, Favour Felix-Ilemhenbhio, et al.
Molecular Cancer Therapeutics|April 18, 2009
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Karen Lundgren, Hong Zhang, John Brekken, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
May the Odds Be Ever in Your Favor: Non-deterministic Mechanisms Diversifying Cell Surface Molecule ExpressionDonnell L Williams, Veronica Maria Sikora, Max A Hammer, et al.
Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatmentE An, C-Y Ock, T-Y Kim, et al.
Journal of Medicinal Chemistry|January 20, 2006
Orally active purine-based inhibitors of the heat shock protein 90Marco A Biamonte, Jiandong Shi, Kevin Hong, et al.
Journal of Medicinal Chemistry|August 18, 2006
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitorsLin Zhang, Junhua Fan, Khang Vu, et al.
Journal of Medicinal Chemistry|September 4, 2012
EC144 is a potent inhibitor of the heat shock protein 90Jiandong Shi, Ryan Van de Water, Kevin Hong, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Nature|January 1, 2004
A large population of 'Lyman-break' galaxies in a protocluster at redshift z approximately 4.1George K Miley, Roderik A Overzier, Zlatan I Tsvetanov, et al.
Pageof 45

Showing results (361-370 of 449) with videos related to

Sort By:
Pageof 45
Stroke|February 12, 2026
Intergenerational Conditioning via Intermittent Parental Hypoxia Confers Stroke Resilience in OffspringAhmet B Caglayan, Mustafa C Beker, Favour Felix-Ilemhenbhio, et al.
Molecular Cancer Therapeutics|April 18, 2009
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Karen Lundgren, Hong Zhang, John Brekken, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
May the Odds Be Ever in Your Favor: Non-deterministic Mechanisms Diversifying Cell Surface Molecule ExpressionDonnell L Williams, Veronica Maria Sikora, Max A Hammer, et al.
Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatmentE An, C-Y Ock, T-Y Kim, et al.
Journal of Medicinal Chemistry|January 20, 2006
Orally active purine-based inhibitors of the heat shock protein 90Marco A Biamonte, Jiandong Shi, Kevin Hong, et al.
Journal of Medicinal Chemistry|August 18, 2006
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitorsLin Zhang, Junhua Fan, Khang Vu, et al.
Journal of Medicinal Chemistry|September 4, 2012
EC144 is a potent inhibitor of the heat shock protein 90Jiandong Shi, Ryan Van de Water, Kevin Hong, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Nature|January 1, 2004
A large population of 'Lyman-break' galaxies in a protocluster at redshift z approximately 4.1George K Miley, Roderik A Overzier, Zlatan I Tsvetanov, et al.
Pageof 45